Application of loganin in preparation of drugs for preventing or treating arrhythmia

A loganin and arrhythmia technology, which is applied in the field of medicine, can solve problems such as the anti-arrhythmic biological activity or clinical application research of logangenin, which is not seen, and achieves improvement of therapeutic effect and quality of life, significant therapeutic effect, and human body. Effects with low side effects

Active Publication Date: 2019-09-06
LUNAN PHARMA GROUP CORPORATION
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] So far, there is no research on the antiarrhythmic biological activity or clinical application of loganinin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of loganin in preparation of drugs for preventing or treating arrhythmia
  • Application of loganin in preparation of drugs for preventing or treating arrhythmia
  • Application of loganin in preparation of drugs for preventing or treating arrhythmia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1 loganin tablet

[0021]

[0022] Preparation process: Mix loganin, microcrystalline cellulose and sodium carboxymethyl starch evenly, add appropriate amount of starch slurry to make soft material, and pass through a 16-mesh sieve to granulate. The wet granules are dried at 60°C, the dry granules are passed through a 20-mesh sieve for granulation, the fine powder in the dry granules is screened out, mixed with magnesium stearate, and then mixed with the dry granules, pressed into tablets, each tablet is about 200mg, that is, .

Embodiment 2

[0023] Embodiment 2 loganin tablet

[0024]

[0025] Preparation process: mix the loganin starch and dextrin in the prescribed amount evenly. In addition, add an appropriate amount of 50% ethanol to the mixed powder, mix evenly, make soft material, pass through a 18-mesh nylon sieve to make wet granules, and dry at about 60°C. The moisture content of the dry granules should be controlled below 1.5%. Sieve through a 20-mesh sieve, mix with magnesium stearate, and press into tablets.

Embodiment 3

[0026] Embodiment 3 loganin capsules

[0027] Loganin 10g

[0028] Microcrystalline Cellulose 300g

[0029] Micronized silica gel 12g

[0030] Preparation process: pulverize loganin, microcrystalline cellulose, and micropowder silica gel, pass through a 100-mesh sieve, mix well, and directly fill capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to uses of loganetin in preparation of drugs for prevention or treatment of arrhythmia, and belongs to the field of medicine. According to the present invention, the loganetin is the tradition Chinese medicine monomer extracted from the traditional Chinese medicine; the animal test results show that the loganetin can significantly prevent and treat arrhythmia, can significantly delay the occurrence of premature ventricualr contraction, ventricular tachycardia and ventricular fibrillation of arrhythmia rats due to aconitine, can significantly reduce the animal mortality, and can significantly inhibit the ventricular fibrillation incidence rate of chloroform-induced arrhythmia mice; and the loganetin has advantages of exact arrhythmia treatment effect, low side effect, and broad medical application prospect.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a medical application of loganin, in particular to the medical application of loganin in the preparation of drugs for preventing or treating arrhythmia. Background technique [0002] Cardiac arrhythmia is a common and frequently-occurring disease in the field of cardiovascular diseases, and its mechanism can be summarized as abnormal impulse formation, abnormal conduction, or both abnormal impulse formation and conduction. Cardiac arrhythmia is one of the most serious diseases among cardiovascular system diseases. The danger of arrhythmia is that it can not only aggravate the original heart disease, such as accelerating the progress of heart failure, but also lead to sudden death of the patient, which seriously threatens human health. Ischemic heart disease is the main cause of malignant arrhythmias such as ventricular tachycardia and ventricular fibrillation; heart failure is also an impor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352A61P9/06
Inventor 张贵民牟丽丽李会恩张晓敏赵云
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap